Leinao.ai raises $15M Series B to build out inference-scheduling tools
What's the deal? Chinese brain-intelligence startup Leinao.ai has raised 100 million yuan (roughly $15 million) in a Series B round, the company said. CRRC Capital, the investment arm of state-owned CRRC CorporationDealroom has a profile for this one. Try Dealroom →, led the round.
Who else is in? Ginkgo Valley CapitalDealroom has a profile for this one. Try Dealroom →, Shuimu Fund, and Qidi Fund also participated. The round follows an earlier Series B investment from a China MobileDealroom has a profile for this one. Try Dealroom →-affiliated fund in 2025.
What's the endgame? Leinao.ai will use the proceeds to develop heterogeneous computing-power scheduling and token optimisation for inference workloads. It also plans to expand its "token-factory" industrial services, which link power, computing, and tokens in decision-making systems.
By the numbers: The round ranks in the 96th percentile by size among Series B health deals in China over the trailing 48 months, based on a sample of 292 rounds.
The signal: Backing from a central state-owned enterprise and a prior China Mobile-linked fund points to state-connected capital steering money toward domestic AI infrastructure, particularly the compute-scheduling layer that inference at scale depends on.
Read more: en.tmtpost.com
Image credit: Generated with Gemini
